Patients with @ CFH risk alleles and no ARMS@ risk alleles progressed more with zinc-containing treatment compared with placebo , with a hazard ratio ( HR ) of @ ( P = @ ) for zinc and @ ( P = @ ) for AREDS formulation ( AF ) .